NCT02155985 - Modulation of Immune Activation by Aspirin | Biotech Hunter

Enrollment

121

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions

HIV-1 Infection

Interventions

DRUG

Aspirin

Aspirin is a nonsteroidal antiinflammatory drug (NSAID) effective in treating fever, pain, and inflammation in the body.

DRUG

Placebo

Placebo for aspirin

Trial Locations (15)

27401

Greensboro CRS (3203), Greensboro

27516

3201 Chapel Hill CRS, Chapel Hill

37204

3652 Vanderbilt Therapeutics (VT) CRS, Nashville

44106

Case CRS (2501), Cleveland

45267

Univ. of Cincinnati CRS (2401), Cincinnati

60611

2701 Northwestern University CRS, Chicago

60612

Rush Univ. Med. Ctr. ACTG CRS (2702), Chicago

77030

Houston AIDS Research Team CRS (31473), Houston

80045

University of Colorado Hospital CRS (6101), Aurora

90035

601 University of California, Los Angeles CARE Center CRS, Los Angeles

90502

Harbor-UCLA Med. Ctr. CRS (603), Torrance

92103

701 University of California, San Diego AntiViral Research Center CRS, San Diego

94110

Ucsf Aids Crs (801), San Francisco

02114

Massachusetts General Hospital ACTG CRS (101), Boston

02115

Brigham and Women's Hosp. ACTG CRS (107), Boston

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK